All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for GENENTECH INC · Biopharmaceutical company

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

HOUSE OF REPRESENTATIVES
SENATE
U.S. Trade Representative (USTR)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Health Issues

Issues related to public health preparedness; Issues related to access to drugs for minority communities; Issues related to healthcare education and screening.

Trade (domestic/foreign)

Issues related to intellectual property rights in foreign countries.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.